| 000 | 01840 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518000026.0 | ||
| 264 | 0 | _c20190815 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1532-2394 | ||
| 024 | 7 |
_a10.1080/08982104.2018.1524483 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalem, Heba F | |
| 245 | 0 | 0 |
_aProgesterone-loaded nanosized transethosomes for vaginal permeation enhancement: formulation, statistical optimization, and clinical evaluation in anovulatory polycystic ovary syndrome. _h[electronic resource] |
| 260 |
_bJournal of liposome research _cJun 2019 |
||
| 300 |
_a183-194 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Intravaginal |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlginates _xchemistry |
| 650 | 0 | 4 | _aAnovulation |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypromellose Derivatives _xchemistry |
| 650 | 0 | 4 |
_aLetrozole _xadministration & dosage |
| 650 | 0 | 4 |
_aLiposomes _xchemistry |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 | _aOvulation Induction |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 |
_aPolycystic Ovary Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Rate |
| 650 | 0 | 4 |
_aProgesterone _xadministration & dosage |
| 650 | 0 | 4 |
_aProgestins _xadministration & dosage |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aVaginal Creams, Foams, and Jellies |
| 700 | 1 | _aKharshoum, Rasha M | |
| 700 | 1 | _aAbou-Taleb, Heba A | |
| 700 | 1 | _aAbouTaleb, Hisham A | |
| 700 | 1 | _aAbouElhassan, Kariman M | |
| 773 | 0 |
_tJournal of liposome research _gvol. 29 _gno. 2 _gp. 183-194 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/08982104.2018.1524483 _zAvailable from publisher's website |
| 999 |
_c28841645 _d28841645 |
||